ZA200601974B - Method for detecting procoagulant phospholipid - Google Patents

Method for detecting procoagulant phospholipid Download PDF

Info

Publication number
ZA200601974B
ZA200601974B ZA200601974A ZA200601974A ZA200601974B ZA 200601974 B ZA200601974 B ZA 200601974B ZA 200601974 A ZA200601974 A ZA 200601974A ZA 200601974 A ZA200601974 A ZA 200601974A ZA 200601974 B ZA200601974 B ZA 200601974B
Authority
ZA
South Africa
Prior art keywords
plasma
phospholipid
reagent
substrate plasma
procoagulant
Prior art date
Application number
ZA200601974A
Other languages
English (en)
Inventor
Exner Thomas
Original Assignee
Haematex Res Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2003905172A external-priority patent/AU2003905172A0/en
Application filed by Haematex Res Pty Ltd filed Critical Haematex Res Pty Ltd
Publication of ZA200601974B publication Critical patent/ZA200601974B/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • HELECTRICITY
    • H03ELECTRONIC CIRCUITRY
    • H03LAUTOMATIC CONTROL, STARTING, SYNCHRONISATION OR STABILISATION OF GENERATORS OF ELECTRONIC OSCILLATIONS OR PULSES
    • H03L7/00Automatic control of frequency or phase; Synchronisation
    • H03L7/06Automatic control of frequency or phase; Synchronisation using a reference signal applied to a frequency- or phase-locked loop
    • H03L7/16Indirect frequency synthesis, i.e. generating a desired one of a number of predetermined frequencies using a frequency- or phase-locked loop
    • H03L7/22Indirect frequency synthesis, i.e. generating a desired one of a number of predetermined frequencies using a frequency- or phase-locked loop using more than one loop

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
ZA200601974A 2003-09-22 2004-09-22 Method for detecting procoagulant phospholipid ZA200601974B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AU2003905172A AU2003905172A0 (en) 2003-09-22 Method for Detecting Procoagulant Phospholipid

Publications (1)

Publication Number Publication Date
ZA200601974B true ZA200601974B (en) 2007-05-30

Family

ID=34318306

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200601974A ZA200601974B (en) 2003-09-22 2004-09-22 Method for detecting procoagulant phospholipid

Country Status (16)

Country Link
US (2) US20060228765A1 (de)
EP (1) EP1668373B1 (de)
JP (1) JP4559426B2 (de)
KR (1) KR20060113662A (de)
CN (1) CN1856710B (de)
AT (1) ATE447717T1 (de)
BR (1) BRPI0414293A (de)
CA (1) CA2539034A1 (de)
DE (1) DE602004023957D1 (de)
ES (1) ES2333872T3 (de)
IL (1) IL174156A0 (de)
MX (1) MXPA06003192A (de)
NO (1) NO20061240L (de)
RU (1) RU2006107577A (de)
WO (1) WO2005029093A1 (de)
ZA (1) ZA200601974B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005028018A1 (de) * 2005-06-16 2006-12-21 Dade Behring Marburg Gmbh Verfahren zur Standardisierung von Gerinnungstesten
IS2809B (is) * 2011-03-08 2012-10-15 Haskoli Islands Blóðstorkumæling
CN110088628B (zh) * 2016-12-14 2023-05-16 豪夫迈·罗氏有限公司 对样品中干扰物的确定
CN109490557A (zh) * 2018-11-23 2019-03-19 福州长庚医疗器械有限公司 一种运用血液凝固方式测量促凝剂效果的检测方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6248553B1 (en) * 1998-10-22 2001-06-19 Atairgin Technologies, Inc. Enzyme method for detecting lysophospholipids and phospholipids and for detecting and correlating conditions associated with altered levels of lysophospholipids

Also Published As

Publication number Publication date
KR20060113662A (ko) 2006-11-02
CN1856710B (zh) 2012-06-13
RU2006107577A (ru) 2007-10-27
ES2333872T3 (es) 2010-03-02
NO20061240L (no) 2006-05-31
EP1668373A4 (de) 2007-01-10
IL174156A0 (en) 2006-08-01
CN1856710A (zh) 2006-11-01
WO2005029093A1 (en) 2005-03-31
EP1668373B1 (de) 2009-11-04
JP4559426B2 (ja) 2010-10-06
US20090221012A1 (en) 2009-09-03
BRPI0414293A (pt) 2006-11-07
US20060228765A1 (en) 2006-10-12
EP1668373A1 (de) 2006-06-14
ATE447717T1 (de) 2009-11-15
JP2007505636A (ja) 2007-03-15
MXPA06003192A (es) 2006-12-14
CA2539034A1 (en) 2005-03-31
DE602004023957D1 (de) 2009-12-17

Similar Documents

Publication Publication Date Title
Marsh et al. Practical applications of snake venom toxins in haemostasis
Martinoli et al. Fast functional protein C assay using protac® a novel protein C activator
US5705198A (en) Test for lupus anticoagulant
JP2003517610A (ja) 血液学的アッセイ及び試薬
JPH04506603A (ja) 血漿プロテインの検定方法
US5726028A (en) Method for detecting disturbances of the protein c/protein s system
JPH08220091A (ja) 活性化状態の活性化タンパク質cに対する安定性が増大された凝固v因子を特異的に検出する方法
US20090221012A1 (en) Method for Detecting Procoagulant Phospholipid
Joseph et al. Effect of snake venom procoagulants on snake plasma: implications for the coagulation cascade of snakes
Girolami et al. Chromogenic Substrate (S-2238) Prothrombin Assay in Prothrombin Deficiencies and Abnormalities. Lack of Identity with Clotting Assays in Congenital Dysprothrombinemias.
AU2004274516B2 (en) Method for detecting procoagulant phospholipid
Marsh Use of snake venom fractions in the coagulation laboratory
Meier et al. Snake venom protein C activators
Perchuc et al. Diagnostic use of snake venom components in the coagulation laboratory
AU729843B2 (en) Method for the functional detection of disorders in the protein C system
JP3600667B2 (ja) 欠損凝固v因子を検出する試験方法で使用するためのキャリブレータ
van de Waart et al. A functional test for protein S activity in plasma
Mannhalter Biochemical and functional properties of factor XI and prekallikrein
Phillips et al. Effects of puff adder venom on the coagulation mechanism
HK1093365A (en) Method for detecting procoagulant phospholipid
Esmon The role of protein C and thrombomodulin in the regulation of blood coagulation
Busch Factors influencing human thrombin generation during fibrin glue manufacturing
Ahmed Coagulation Factor (Excluding Factor VIII) Autoantibodies